Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gap junction alpha-8 protein is a member of the connexin family, forming hexameric connexons that dock between neighboring cells to create gap junction channels[2][3][6]. These channels facilitate the direct diffusion of ions, metabolites, and signaling molecules below 1 kDa, crucial for maintaining lens homeostasis and transparency[4][5][7]. GJA8 is highly expressed in the lens, and to a lesser extent in the cornea and other ocular tissues[7], and is essential for lens growth, fiber cell differentiation, and cell adhesion. Mutations cause a variety of inherited ocular disorders, often congenital and involving both lens structure and transparency. Genetic studies identify dominant, de novo missense, and microdeletion variants with variable penetrance and severity[5][7].
Drugs or antibodies targeting GJA8 affect gap junction channel formation and function, thereby modulating lens fiber cell communication and lens transparency.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gap junction alpha-8 protein (GJA8 (Connexin-50; Cx50)).